Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Zarkin

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Health Services Research|May 6, 2008
Examining variation in treatment costs: a cost function for outpatient methadone treatment programsLaura J Dunlap, Gary A Zarkin, Alexander J Cowell
Drug and Alcohol Dependence|January 11, 2016
Nonmedical prescription pain reliever and alcohol consumption among cannabis usersScott P Novak, Nicholas C Peiper, Gary A Zarkin
JAMA Network Open|April 21, 2020
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare BeneficiariesTami L Mark, William J Parish, Gary A Zarkin
Journal of Substance Use and Addiction Treatment|July 31, 2025
Estimates of first-year OTC naloxone sales in four U.S. states with high rates of opioid overdose deaths: KY, MA, NY, OHDoris G Gammon, Jennifer Gaber, McKinley Saunders, et al.
Psychiatric Services (Washington, D.C.)|July 25, 2020
Comparison of Medicaid Reimbursements for Psychiatrists and Primary Care PhysiciansTami L Mark, William Parish, Gary A Zarkin, et al.
Substance Use & Misuse|August 2, 2007
Do treatment services for drug users in outpatient drug-free treatment programs affect employment and crime?Laura J Dunlap, Gary A Zarkin, Rik Lennox, et al.
Medical Care|June 13, 2015
The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in ArizonaJesse M Hinde, Jeremy W Bray, Arnie Aldridge, et al.
Evaluation and Program Planning|July 22, 2008
The effect of alternative staff time data collection methods on drug treatment service cost estimatesGary A Zarkin, Laura J Dunlap, Brendan Wedehase, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2023
Association of Arizona's Implementation of a Behavioral Health Crisis Response System With Suicide HospitalizationsTami L Mark, Kristen Henretty, Brent J Gibbons, et al.
Health Economics|May 10, 2005
Benefits and costs of methadone treatment: results from a lifetime simulation modelGary A Zarkin, Laura J Dunlap, Katherine A Hicks, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Health Services Research|May 6, 2008
Examining variation in treatment costs: a cost function for outpatient methadone treatment programsLaura J Dunlap, Gary A Zarkin, Alexander J Cowell
Drug and Alcohol Dependence|January 11, 2016
Nonmedical prescription pain reliever and alcohol consumption among cannabis usersScott P Novak, Nicholas C Peiper, Gary A Zarkin
JAMA Network Open|April 21, 2020
Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare BeneficiariesTami L Mark, William J Parish, Gary A Zarkin
Journal of Substance Use and Addiction Treatment|July 31, 2025
Estimates of first-year OTC naloxone sales in four U.S. states with high rates of opioid overdose deaths: KY, MA, NY, OHDoris G Gammon, Jennifer Gaber, McKinley Saunders, et al.
Psychiatric Services (Washington, D.C.)|July 25, 2020
Comparison of Medicaid Reimbursements for Psychiatrists and Primary Care PhysiciansTami L Mark, William Parish, Gary A Zarkin, et al.
Substance Use & Misuse|August 2, 2007
Do treatment services for drug users in outpatient drug-free treatment programs affect employment and crime?Laura J Dunlap, Gary A Zarkin, Rik Lennox, et al.
Medical Care|June 13, 2015
The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in ArizonaJesse M Hinde, Jeremy W Bray, Arnie Aldridge, et al.
Evaluation and Program Planning|July 22, 2008
The effect of alternative staff time data collection methods on drug treatment service cost estimatesGary A Zarkin, Laura J Dunlap, Brendan Wedehase, et al.
Psychiatric Services (Washington, D.C.)|August 9, 2023
Association of Arizona's Implementation of a Behavioral Health Crisis Response System With Suicide HospitalizationsTami L Mark, Kristen Henretty, Brent J Gibbons, et al.
Health Economics|May 10, 2005
Benefits and costs of methadone treatment: results from a lifetime simulation modelGary A Zarkin, Laura J Dunlap, Katherine A Hicks, et al.
Pageof 9